Related Experiment Video
Updated: Mar 24, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes Mellitus: Screening and Diagnosis
Karly Pippitt1, Marlana Li1, Holly E Gurgle2
1University of Utah School of Medicine, Salt Lake City, UT, USA.
Screening for type 2 diabetes aids early diagnosis but doesn't reduce mortality within 10 years. Lifestyle interventions can prevent progression in prediabetes, while type 1 diabetes screening is not advised.
Area of Science:
- Endocrinology
- Preventive Medicine
- Family Medicine
Background:
- Diabetes mellitus is a prevalent diagnosis with severe complications including blindness, amputation, and cardiovascular disease.
- Early detection through screening can lead to timely diagnosis and treatment, though its impact on long-term mortality and end-organ damage is debated.
- Screening guidelines vary, with recommendations from organizations like the U.S. Preventive Services Task Force and the American Diabetes Association focusing on specific age groups and risk factors.
Purpose of the Study:
- To review current recommendations and evidence regarding screening for type 1 and type 2 diabetes.
- To outline diagnostic criteria for diabetes mellitus.
- To discuss the role of lifestyle interventions in managing prediabetes.
Main Methods:
- Review of randomized trials and guidelines from major health organizations.
- Analysis of diagnostic criteria including fasting plasma glucose, A1C, and oral glucose tolerance tests.
- Evaluation of the effectiveness of screening and interventions for diabetes prevention and management.
Main Results:
- Screening for type 2 diabetes does not reduce mortality at 10 years, but potential long-term benefits (23-30 years) are suggested.
- Lifestyle and pharmacologic interventions are effective in decreasing diabetes progression in individuals with impaired glucose metabolism.
- Screening for type 1 diabetes is not recommended. Recommended screening for type 2 diabetes targets adults aged 40-70 who are overweight or obese, with repeat testing every three years, and annual screening for those 45+ or younger individuals with risk factors.
Conclusions:
- Screening for type 2 diabetes is recommended for specific adult populations, with varying frequencies based on age and risk factors.
- Diagnostic criteria for diabetes are well-established, requiring confirmation with repeat testing unless clear symptoms are present.
- Interventions are crucial for managing prediabetes and preventing progression to type 2 diabetes.
More Related Videos
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...